Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ventures III Lp Aberdare currently holds 49,712 shares of Conatus Pharmaceuticals Inc (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures III Lp Aberdare has been a net buyer of CNAT stock. They have purchased $1.2M and sold $6.2K worth of shares.
Ventures III Lp Aberdare's most recent insider trade was on Jul 30, 2013, when they sold 1,727 shares at $0.08 per share.
Ventures III Lp Aberdare serves as Executive at Conatus Pharmaceuticals Inc (CNAT). They have executed 10 insider transactions totaling $1.2M over their tenure at the company.
Ventures III Lp Aberdare holds the position of Executive at Conatus Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Ventures III Lp Aberdare has shown a buying trading pattern, with $1.2M in total purchases and $6.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ventures III Lp Aberdare was on Jul 30, 2013, when they purchased $1.2M worth of CNAT shares. This transaction involved 104,952 shares at $11.00 per share.
Ventures III Lp Aberdare currently owns 49,712 shares of Conatus Pharmaceuticals Inc (CNAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ventures III Lp Aberdare's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ventures III Lp Aberdare has 10 Form 4 filings on record as an insider at Conatus Pharmaceuticals Inc.
Set alerts for Ventures III Lp Aberdare and 40,000+ other insiders.